to those previously obtained (Oakey et al. 1967 ). This shows more clearly the levelling off to a plateau in mean cestrogen excretion.
The study revealed a positive correlation between estrogen excretion and both placental weight and birth weight. The ratio of placental weight to birth weight, the placental coefficient, also showed a positive correlation to cestrogen excretion, i.e. in prolonged pregnancies increased cstrogen excretion was associated with higher placental coefficients. This might be thought to contradict the pre-term situation where falling placental weight/birth weight ratios are associated with increasing aestrogen excretion as pregnancy advances.
There were no stillbirths or neonatal deaths in this series. However, signs of fetal asphyxia occurred in labour in 31 cases (16-5 %) . Signs of factal asphyxia in labour occurred much more often in patients with low cestrogen excretion than in those with normal oestrogen excretion. Normal excretion, however, did not entirely exclude the development of signs of feetal asphyxia in labour. In 10 of the 31 cases of fetal distress, there was no factor apparent, other than prolongation of pregnancy, to account for the foetal distress. Of these 10 cases, 9 had low or falling aestrogen excretion before the onset of labour. Of 88 patients with low or falling cestrogen excretion, 45 were allowed to come into labour spontaneously and 43 had labour induced because of the low or falling estrogen excretion. Of the first group 22 developed signs offetal asphyxia in labour, whilst only 9 showed similar signs in the second group: low and falling cestrogen excretion was apparently associated with reduced resistance to the hypoxic stress oflabour.
Conclusions
There has been little information available concerning maternal urinary cestrogen excretion in prolonged pregnancies. The group studied showed that levels of urinary excretion noted in normal pregnancies at term were sustained at a constant level in prolonged pregnancy. Previously reported (Jayle et al. 1964) positive correlation between placental weights and aestrogen excretion and birth weights and cestrogen excretion were confirmed in this study. There is reason to believe that low or falling cestrogen excretion in prolonged pregnancy will help select those cases of increased fetal risk in prolonged pregnancy. Early suspicion of serious placental insufficiency by serial estimations of urinary cestrogen excretion can only be achieved if results are available for each 24-hour collection at least within six to eight hours. This allows for the prompt action required. Poor feetal growth has been described under many names and may be due to a variety of causes. Apart from the small series of Martin & Hahnel (1964) there are no reports on endocrine studies in this condition if one excludes work in which the patients' symptoms were either not clearly defined or included some characteristics of pre-eclampsia. Only the small-for-dates cases without any other obvious abnormality have been considered in this series and for this group the term small-for-dates syndrome (Morris 1968 ) is the most satisfactory one available. Particular care was taken to exclude all patients whose blood pressure had exceeded 140/90 mmHg on any occasion.
Preliminary studies soon showed that as clinical estimates of poor fetal growth were not a reliable guide to poor placental function or to the eventual delivery of a small baby, it was desirable that further screening should be carried out. The value of a single urinary pregnanediol determination as a screening test was therefore assessed using the gas chromatographic method of Brush et al. (1966) . This method, while otherwise comparable with earlier methods, is much faster.
Our experience of this screening test over the last five years is summarized in Table 1 . This shows that if the lower limit of the normal range is used as the criterion for judging the result, the predictions of fcetal size show an appreciable error, with 49 small babies being delivered out of 211 cases with a normal screening pregnanediol. However, if the results in the lower 25 % of the normal pregnanediol range are added to the low results, more than 50% of the small babies are removed from the normal pregnanediol group. Of the remainder, 18 out of 23 were only just below the normal weight limits and some of the remaining few cases could be accounted for by pathology subsequent to the screening test. These findings showed that the lower limit of the normal range was not a satisfactory criterion in all circumstances and that all patients whose screening value fell in the lower 25 % of the normal range should, whenever possible, be followed by further pregnanediol determinations and, if possible, by urinary aestriol determinations.
Where the screening pregnanediol value was low but the babies' weight was normal, it seemed probable that placental impairment was subsequent to the growth of the fcetus to a normal size. Where no placental damage had occurred, rest usually produced a rise to normal pregnanediol values. When both screening pregnanediol and baby weight were low, the placenta was either very small for time of gestation, showed structural damage, or was both small and damaged.
Experience with multiple pregnanediol determinations, supplemented by urinary cestriol determinations by the gas chromatographic method of Wotiz & Martin (1961, as modified by Brush & Maxwell, unpublished) has shown their value in following cases at risk and in deciding when to effect early delivery, if necessary. A steady rise in pregnanediol values is almost always a reassuring index.
However, where pregnanediol excretion remains essentially unchanged at low levels over several weeks, or falls, there is serious risk of placental failure. This may lead to intrauterine death or damage to a surviving infant. Therefore, if low levels are maintained for too long or if several successive falling values are seen, delivery should be induced, provided the pregnancy has reached 32-34 weeks. Providing that anoxic damage to the fcetus has been avoided the infants usually thrive. This was shown by the low inci-dence of neonatal deaths in this series, and emphasizes that where intrauterine death does occur in this condition the primary failure is almost always placental rather than foetal. Urinary cestriol values have followed trends similar to those for pregnanediol in this series and, in particular, have not been very low when pregnanediol values were satisfactory.
A number of placentas from cases with low steroid excretion have been histologically examined. The majority showed significant intervillous fibrin deposition. Other defects included macroscopic infarcts which were sometimes up to 30-40% of the total placenta, intravillous fibrin and syncytial knotting. This incidence ofplacental pathology is greatly in excess of its incidence in 'normal' pregnancies (Wigglesworth 1964) .
The causes of this poor foetal growth may be genetic or due to placental deficiencies. When placental growth is poor but no placental damage is seen, the cause may be genetic or environmental, e.g. nutrition, anemia, or smoking. These reasons can only account for a limited number of cases. It seems likely that more are due to placental pathology of unknown origin. In view of the findings of Fox (1968) an immunological reaction must be considered. In certain cases it is possible that a rapid functional failure takes place due to specific biochemical defect, in particular in enzyme systems. In order to investigate whether a defect in placental steroid biosynthesis occurred in cases of placental failure, studies on the biosynthesis in vitro of progesterone from pregnenolone have been carried out using portions of tissue from different parts of the placenta. The precursor steroid was 7-3H-pregnenolone and standard incubation conditions were used.
The results showed that there was no significant impairment of this conversion until gross tissue damage was seen, i.e. heavy fibrin deposition or frank infarct. It is probable that the decline in placental progesterone production, as followed by pregnanediol excretion in these cases of placental failure, is due to decrease in total mass of functional tissue rather than to qualitative change in the metabolism of pregnenolone. Studies on the biosynthesis of pregnenolone from cholesterol are in progress.
